Abstract
Background
Sebaceous neoplasms (SNs) and carcinomas (SCs) represent rare skin adnexal tumours.
Objectives
To establish the prevalence of HPV in SNs, assess the relationship between HPV, p16 and p53 expression, and further elucidate the carcinogenetic course of SCs.
Materials & Methods
A total of 113 resected SNs (five sebaceous adenomas, 10 sebaceomas and 98 SCs) from the Near-East were reviewed. Clinical information (age, gender, size and anatomical location), microscopic variables, and expression of several immunohistochemical markers (EMA, CK5/6, p63, p40, AR, p16 and p53) were documented. Cases were evaluated by fluorescently labelled PCR for HPV detection, followed by DNA microarray hybridization for subtype detection.
Results
HPV infection was detected in 9.4% of SNs: 28.6% sebaceous adenomas (HPV-16 and HPV-66), 9.1% sebaceomas (HPV-18) and 8.1% SCs. High-risk HPV types (HPV-16, −18, −52 and −66) constituted 90.9% of HPV infections. Histologically, HPV-positive SCs showed significantly milder cytologic atypia and patchy cellular necrosis. p16 was expressed in SNs irrespective of HPV status (20.0%, 33.3% and 65.5% of HPV-negative sebaceous adenomas, sebaceomas, and SCs, respectively), and p53 was abnormally expressed in 95.5% of HPV-negative SCs and all HPV-positive SCs.
Conclusion
HPV infection is significantly present in benign and malignant SNs. HPV-positive SCs exhibit less cytologic atypia and necrosis than HPV-negative cases. p16 is not a surrogate marker of HPV infection in the SN setting. Further elucidation of various carcinogenic mechanisms in SCs will allow clinicians to single out the various populations at risk, optimize possible preventive strategies and develop targeted therapies
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Viarisio D, Gissmann L, Tommasino M. Human papillomaviruses and carcinogenesis: well-established and novel models. Curr Opin Virol 2017; 26: 56–62.
Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J Clin Med 2018; 7: 9.
Cattani P, Zannoni GF, Ricci C, et al. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 2009; 47: 3895–901.
Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, et al. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology 1998; 105: 497–506.
Hayashi N, Furihata M, Ohtsuki Y, Ueno H. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch 1994; 424: 503–9.
Stagner AM, Afrogheh AH, Jakobiec FA, et al. p16 expression is not a surrogate marker for high-risk human papillomavirus infection in periocular sebaceous carcinoma. Am J Ophthalmol 2016; 170: 168–75.
Weedon D, Strutton G, Rubin A. Weedon’s Skin Pathology. Edinburgh: Churchill Livingstone/Elsevier, 2010.
Accardi R, Gheit T. Cutaneous HPV and skin cancer. Presse Med 2014; 43(12): e435–43.
Rollison DE, Viarisio D, Amorrortu RP, Gheit T, Tommasino M. An emerging issue in oncogenic virology: the role of beta human papillomavirus types in the development of cutaneous squamous cell carcinoma. J Virol 2019; 93: 7.
Requena L, Sangüeza O. Embryology, Anatomy, Histology, and Physiology of the Sebaceous Glands. Cutaneous Adnexal Neoplasms. Cham: Springer International Publishing, 2017: 755–64.
Niemann C. Differentiation of the sebaceous gland. Dermatoendocrinol 2009; 1: 64–7.
Frances D, Niemann C. Stem cell dynamics in sebaceous gland morphogenesis in mouse skin. Dev Biol 2012; 363: 138–46.
Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses 2015; 7: 3863–90.
Liau JY, Liao SL, Hsiao CH, Lin MC, Chang HC, Kuo KT. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Hum Pathol 2014; 45: 533–9.
Tetzlaff MT, Curry JL, Ning J, et al. Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations. Clin Cancer Res 2019; 25: 1280–90.
Conscience I, Jovenin N, Coissard C, et al. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol 2006; 16: 518–22.
Shalin SC, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar AJ. p53 staining correlates with tumor type and location in sebaceous neoplasms. Am J Dermatopathol 2012; 34: 129–35.
Hussain RM, Matthews JL, Dubovy SR, Thompson JM, Wang G. UV-independent p53 mutations in sebaceous carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg 2014; 30: 392–5.
Cabral ES, Auerbach A, Killian JK, Barrett TL, Cassarino DS. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry. Am J Dermatopathol 2006; 28: 465–71.
North JP, Golovato J, Vaske CJ, et al. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nature Commun 2018; 9: 1894.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Financial support: none. Conflicts of interest: none.
About this article
Cite this article
Saliba, M., Shaheen, M., El Hajj, R. et al. Sebaceous neoplasms: prevalence of HPV infection and relation to immunohistochemical surrogate markers. Eur J Dermatol 31, 170–175 (2021). https://doi.org/10.1684/ejd.2021.4008
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2021.4008